Nihon Medi-Physics Collaboration on Actinium Renal Cancer
Filed with ASX · · 2 pages · English
Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings CallTelix Pharmaceuticals Limited on 6ix
Earlier from Telix Pharmaceuticals
- ANMI Transaction - Market Briefing
- Telix Acquires Advanced Nuclear Medicine Ingredients SA
- Appendix 4C - September Quarter
- Telix Commences ZIRCON Phase III Renal Cancer Imaging Trial
- Interim Analysis of ZIR-DOSE Study Shows Improved Dosimetry
Later from Telix Pharmaceuticals
- Telix Pharmaceuticals Completes Acquisition of ANMI SA
- Update - Acceleration of Prostate Cancer Therapy Program
- Detailed Program Update - January 2019
- Telix Group Expands Prostate Imaging Capability through ININ
- Appendix 4C - December 2018 quarter
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals